Loading company…
Won a federal SBIR/STTR research award from HHS and other federal agencies.
Kano Therapeutics Inc. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $349,952 in 2025. These are non-dilutive federal research grants, not equity financing. The company is based in Cambridge, Massachusetts.
2 rounds · latest SBIR Phase I award (HHS), Sep 2025
Sign in to see 2 rounds.
Sign inSign in to see 4 investors.
Sign inKano Therapeutics Inc. has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for Kano Therapeutics Inc..
Add diversity data